Tibet Rhodiola Pharmaceutical Holding Co (600211) — Financial Flexibility Index
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Financial Flexibility Index of 0.14x as of December 2025. Free cash flow of CN¥302.85 Million (operating CF CN¥297.86 Million minus capex CN¥4.98 Million) represents 0% of total liabilities (CN¥2.10 Billion). Check Tibet Rhodiola Pharmaceutical Holding Co (600211) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tibet Rhodiola Pharmaceutical Holding Co Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Tibet Rhodiola Pharmaceutical Holding Co across 27 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tibet Rhodiola Pharmaceutical Holding Co.
Annual Financial Flexibility Index for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Year-by-year free cash flow to debt coverage for Tibet Rhodiola Pharmaceutical Holding Co. Explore Tibet Rhodiola Pharmaceutical Holding Co cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥1.04 Billion | CN¥1.03 Billion | CN¥2.10 Billion | ▼ -61.8% |
| 2024 | 1.30x | CN¥1.03 Billion | CN¥994.79 Million | CN¥795.23 Million | ▲ +42.7% |
| 2023 | 0.91x | CN¥1.10 Billion | CN¥1.08 Billion | CN¥1.21 Billion | ▲ +3.5% |
| 2022 | 0.88x | CN¥939.34 Million | CN¥837.38 Million | CN¥1.07 Billion | ▲ +28.5% |
| 2021 | 0.68x | CN¥792.11 Million | CN¥366.53 Million | CN¥1.16 Billion | ▼ -62.5% |
| 2020 | 1.82x | CN¥649.46 Million | CN¥428.17 Million | CN¥355.91 Million | ▲ +8.6% |
| 2019 | 1.68x | CN¥538.59 Million | CN¥489.59 Million | CN¥320.44 Million | ▲ +47.8% |
| 2018 | 1.14x | CN¥312.58 Million | CN¥289.22 Million | CN¥274.89 Million | ▼ -53.7% |
| 2017 | 2.46x | CN¥699.43 Million | CN¥91.46 Million | CN¥284.64 Million | ▲ +1443.8% |
| 2016 | 0.16x | CN¥259.85 Million | CN¥250.21 Million | CN¥1.63 Billion | ▼ -75.7% |
| 2015 | 0.66x | CN¥144.59 Million | CN¥133.93 Million | CN¥220.43 Million | ▲ +465.5% |
| 2014 | -0.18x | CN¥-113.48 Million | CN¥-141.40 Million | CN¥632.26 Million | ▼ -142.3% |
| 2013 | 0.42x | CN¥313.34 Million | CN¥279.22 Million | CN¥738.26 Million | ▲ +221.9% |
| 2012 | 0.13x | CN¥60.62 Million | CN¥56.20 Million | CN¥459.72 Million | ▲ +296.4% |
| 2011 | 0.03x | CN¥14.40 Million | CN¥12.09 Million | CN¥432.93 Million | ▲ +205.5% |
| 2010 | 0.01x | CN¥4.48 Million | CN¥1.90 Million | CN¥411.28 Million | ▼ -77.6% |
| 2009 | 0.05x | CN¥21.59 Million | CN¥17.88 Million | CN¥443.70 Million | ▲ +2.0% |
| 2008 | 0.05x | CN¥26.26 Million | CN¥21.46 Million | CN¥550.51 Million | ▲ +2997.5% |
| 2007 | 0.00x | CN¥-918.00K | CN¥-18.30 Million | CN¥557.68 Million | ▼ -101.6% |
| 2006 | 0.11x | CN¥49.53 Million | CN¥33.63 Million | CN¥470.56 Million | ▲ +73.1% |
| 2005 | 0.06x | CN¥25.99 Million | CN¥18.92 Million | CN¥427.37 Million | ▼ -53.1% |
| 2004 | 0.13x | CN¥44.35 Million | CN¥26.90 Million | CN¥341.74 Million | ▼ -38.9% |
| 2003 | 0.21x | CN¥70.08 Million | CN¥47.20 Million | CN¥329.82 Million | ▼ -50.5% |
| 2002 | 0.43x | CN¥135.00 Million | CN¥32.85 Million | CN¥314.23 Million | ▼ -8.9% |
| 2001 | 0.47x | CN¥95.19 Million | CN¥15.47 Million | CN¥201.82 Million | ▼ -57.2% |
| 2000 | 1.10x | CN¥139.00 Million | CN¥20.55 Million | CN¥126.01 Million | ▼ -21.3% |
| 1999 | 1.40x | CN¥65.50 Million | CN¥2.25 Million | CN¥46.73 Million | — |